Keywords
Type 2 diabetes mellitus
Categories
How to Cite
Abstract
Background: Diabetic Retinopathy (DR) accounts for 5% of the 39 million causes of blindness occurring worldwide
and is estimated to contribute 3% of blindness in Kenya. Dyslipidemia, poor control of sugar, hypertension and
obesity increase the risk of DR in patients with diabetes. This study addresses the gap in information on the
magnitude of DR and its associated factors in patients with type 2 diabetes at Moi Teaching and Referral Hospital
(MTRH).
Objectives: To determine the prevalence and severity of DR and its associated factors in patients with type 2
diabetes mellitus.
Methods: This cross sectional study was conducted amongst patients with type 2 diabetes mellitus in MTRH.
Randomly selected participants underwent anthropometric, laboratory and visual acuity testing. Direct
ophthalmoscopy was used to assess DR and macula edema. Grading of DR was done using international clinical
diabetic retinopathy severity scale. A univariate and multivariate logistic regression model was used to assess
associations of the variables with DR.
Results: Of the 329 participants enrolled, 187 (57%) were female with a mean age of 56.8 (10.99) years. One
hundred and three (31%) had diabetic retinopathy and 39 (12%) had diabetic macula edema. Mild to moderate
non proliferative diabetic retinopathy was the most prevalent grade at 79 (25%). One hundred and eighty
four (56%) of participants had hypertension (133/80; IQR 120/70-150/89) mmHg and 158 (48%) had glycated
haemoglobin between 7-10%. The median for the other assessed factors were as follows: duration of diabetes
5 (9) years, total cholesterol 4.6 (1.3) mmol/l and low density lipoprotein 3.0 (1.5) mmol/l. Increase in duration of
diabetes by 5 years {OR 2.02(95% CI 1.11-3.69); p 0.02}, glycated haemoglobin > 6.5% {OR 2.13(95% CI 1.02-4.42);
p 0.04}, systolic hypertension >160 mmHg {OR 1.02(95% CI 1.01-1.03); p 0.01} were associated with increased
risk of diabetic retinopathy while male gender and body mass index did not. Only 15% of the participants in this
study reported having had previous eye check-up.
Conclusion: A third of patients with type 2 diabetes on follow up at MTRH have DR. Systolic hypertension,
increased duration of diabetes and high glycated haemoglobin were positively associated with increased risk of
developing DR
References
Centre for Disease Control. Diabetes surveillance
system. National diabetes fact sheet. Atlanta,
Georgia. 2003; 302: 43-97.
International Diabetes Federation. Diabetes Atlas
rd Edition. 2006; 10: 5.
Ting DS, Cheung GC, Wong TY. Diabetic retinopathy:
global prevalence, major risk factors, screening
practices and public health challenges: a review. Clin
Exper Ophthalmol. 2016; 44(4):260-277.
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy.
Lancet (London, Engl). 2010; 376(9735):124-136.
Ministry of Health National Strategic plan for eye
care in Kenya 2005-2010, Division of Ophthalmic
Services, Nairobi, Kenya 2005.
Lee R, Wong TY, Sabanayagam C. Epidemiology
of diabetic retinopathy, diabetic macular edema and
related vision loss. Eye Vision. 2015; 2:17.
Control TD, Group CTR. The effect of intensive
treatment of diabetes on the development and
progression of long-term complications in insulindependent
diabetes mellitus. New Engl J Med. 1993;
(14):977-986.
Mbanya JC, Sobngwi E. Diabetes in Africa. Diabetes
microvascular and macrovascular disease in Africa.
J Cardiovas Risk. 2003; 10(2):97-102.
Kohner EM, Aldington SJ, Stratton IM, et al. United
Kingdom Prospective Diabetes Study, 30: diabetic
retinopathy at diagnosis of non-insulin-dependent
diabetes mellitus and associated risk factors. Archives
Ophthalmol (Chicago, Ill.: 1960). 1998; 116(3):297-303.
Mathenge W, Bastawrous A, Peto T, et al. Prevalence
and correlates of diabetic retinopathy in a populationbased
survey of older people in Nakuru, Kenya.
Ophthalmic Epidemiol. 2014; 21(3):169-177.
Njambi L. Prevalence of diabetic retinopathy and
barriers to uptake of diabetic retinopathy screening
at Embu Provincial General Hospital, Central
Kenya. J Ophthalmol East Central South Afr. 2013;
(1):5-11.
Kariuki MM, Kollmann KHM, Adala HS. The
prevalence, pattern and associations of diabetic
retinopathy among black African diabetics attending the
medical diabetes clinic at the Kenyatta National Hospital.
MMed Dissertation, University of Nairobi. 1999.
Bertelsen G, Peto T, Lindekleiv H, et al. Tromso eye
study: prevalence and risk factors of diabetic retinopathy.
Acta ophthalmologica. 2013; 91(8):716-721.
Roy MS, Klein R, O’Colmain BJ, Klein BE, Moss SE,
Kempen JH. The prevalence of diabetic retinopathy
among adult type 1 diabetic persons in the United
States. Archives Ophthalmol (Chicago, Ill. : 1960).
; 122(4):546-551.
Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa
R, Mohan V. Prevalence of diabetic retinopathy in
urban India: the Chennai Urban Rural Epidemiology
Study (CURES) eye study, I. Invest Ophthalmol
Visual Sci. 2005; 46(7):2328-2333.
Effect of intensive blood-glucose control with
metformin on complications in overweight patients
with type 2 diabetes (UKPDS 34). UK Prospective
Diabetes Study (UKPDS) Group. Lancet (London,
England). 1998; 352(9131):854-865.
Stratton IM, Cull CA, Adler AI, Matthews DR, Neil
HA, Holman RR. Additive effects of glycaemia and
blood pressure exposure on risk of complications in
type 2 diabetes: a prospective observational study
(UKPDS 75). Diabetologia. 2006; 49(8):1761-1769.
Klein R, Klein BE, Moss SE, Cruickshanks KJ.
The Wisconsin Epidemiologic Study of Diabetic
Retinopathy: XVII. The 14-year incidence and
progression of diabetic retinopathy and associated
risk factors in type 1 diabetes. Ophthalmology. 1998;
(10):1801-1815.
Ramachandran A, Snehalatha C, Vijay V, Viswanathan
M. Diabetic retinopathy at the time of diagnosis of
NIDDM in south Indian subjects. Diabetes Res Clin
Practice. 1996; 32(1-2):111-114.
Harris MI, Klein R, Welborn TA, Knuiman MW. Onset
of NIDDM occurs at least 4–7 years before clinical
diagnosis. Diabetes Care. 1992; 15(7):815-819.
Dowse G, Humphrey A, Collins V, et al. Prevalence
and risk factors for diabetic retinopathy in the
multiethnic population of Mauritius. Amer J
Epidemiol. 1998; 147(5):448-457.
Burgess P, MacCormick I, Harding S, Bastawrous A,
Beare N, Garner P. Epidemiology of diabetic retinopathy
and maculopathy in Africa: a systematic review. Diabetic
Med. 2013; 30(4):399-412.
Ding J, Wong TY. Current epidemiology of diabetic
retinopathy and diabetic macular edema. Current
Diab Republican J. 2012; 12(4): 346–354.
Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-
Lunar C, Arrieta-Blanco FJ, Gomez- Campelo P.
Four-year incidence of diabetic retinopathy in a
Spanish cohort. The Madrid diabetes study. Lancet.
;46: 376-384.